Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)
Clinical trial NCT01211691 · SUSPENDED
Trial details
- NCT number
- NCT01211691
- Sponsor
- Humanigen, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2016-07-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.